Pharvaris (PHVS) Shares Outstanding (2020 - 2025)
Pharvaris posted quarterly Shares Outstanding of $75.9 million for Q4 2025, up 30.63% year-on-year from $58.1 million in Q4 2024, and up 30.63% on a QoQ basis from $58.1 million in Q4 2024.
Pharvaris (PHVS) has 6 years of Shares Outstanding data on file, last reported at $75.9 million in Q4 2025.
- For the quarter ending Q4 2025, Shares Outstanding rose 30.63% year-over-year to $75.9 million; the trailing twelve-month figure through Dec 2025 stood at $75.9 million (up 30.63% YoY), and the FY2025 full-year result was $73.7 million, up 25.18% from the prior year.
- Shares Outstanding for Q4 2025 stood at $75.9 million, up from $58.1 million in the prior quarter.
- Across five years, Shares Outstanding topped out at $75.9 million in Q4 2025 and bottomed at $34.5 million in Q4 2022.
- The 5-year median for Shares Outstanding is $56.3 million (2023), against an average of $52.5 million.
- The widest annual swing landed in 2021, when Shares Outstanding soared 555.84%; it then slipped 9.03% in 2022.
- A 5-year view of Shares Outstanding shows it stood at $37.9 million in 2021, then slipped by 9.03% to $34.5 million in 2022, then soared by 63.07% to $56.3 million in 2023, then climbed by 3.29% to $58.1 million in 2024, then soared by 30.63% to $75.9 million in 2025.
- The last three Shares Outstanding figures came in at $75.9 million (Q4 2025), $58.1 million (Q4 2024), and $56.3 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 5.21 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 56.35 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 91.57 Bn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 254.16 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.80 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 133.44 Mn |
| 10 | Pharvaris | 267.74 Mn | -73.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 75.91 Mn |
| Dec 31, 2025 | 75.91 Mn |
| Dec 31, 2025 | 75.91 Mn |
| Dec 31, 2025 | 75.91 Mn |
| Dec 31, 2025 | 75.91 Mn |
| Dec 31, 2025 | 75.91 Mn |
| Dec 31, 2025 | 75.91 Mn |
| Dec 31, 2025 | 75.91 Mn |
| Dec 31, 2024 | 58.11 Mn |
| Dec 31, 2024 | 58.11 Mn |
| Dec 31, 2024 | 58.11 Mn |
| Dec 31, 2024 | 58.11 Mn |
| Dec 31, 2024 | 58.11 Mn |
| Dec 31, 2024 | 58.11 Mn |
| Dec 31, 2024 | 58.11 Mn |
| Dec 31, 2024 | 58.11 Mn |
| Dec 31, 2023 | 56.26 Mn |
| Dec 31, 2023 | 56.26 Mn |
| Dec 31, 2023 | 56.26 Mn |
| Dec 31, 2023 | 56.26 Mn |
| Dec 31, 2023 | 56.26 Mn |
| Dec 31, 2023 | 56.26 Mn |
| Dec 31, 2023 | 56.26 Mn |
| Dec 31, 2023 | 56.26 Mn |
| Dec 31, 2022 | 34.50 Mn |
| Dec 31, 2022 | 34.50 Mn |
| Dec 31, 2022 | 34.50 Mn |
| Dec 31, 2022 | 34.50 Mn |
| Dec 31, 2022 | 34.50 Mn |
| Dec 31, 2022 | 34.50 Mn |
| Dec 31, 2022 | 34.50 Mn |
| Dec 31, 2022 | 34.50 Mn |
| Dec 31, 2021 | 37.92 Mn |
| Dec 31, 2021 | 37.92 Mn |
| Dec 31, 2021 | 37.92 Mn |
| Dec 31, 2021 | 37.92 Mn |
| Dec 31, 2021 | 37.92 Mn |
| Dec 31, 2021 | 37.92 Mn |
| Dec 31, 2021 | 37.92 Mn |
| Dec 31, 2021 | 37.92 Mn |
| Dec 31, 2020 | 5.78 Mn |
| Dec 31, 2020 | 5.78 Mn |
| Dec 31, 2020 | 5.78 Mn |
| Dec 31, 2020 | 5.78 Mn |
| Dec 31, 2020 | 5.78 Mn |
| Dec 31, 2020 | 5.78 Mn |
| Dec 31, 2020 | 5.78 Mn |
| Dec 31, 2020 | 5.78 Mn |